{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:02:57Z","timestamp":1788404577937,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.044","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T01:09:00Z","timestamp":1607476140000},"page":"372-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["In-depth analysis of pneumococcal serotypes in Belgian children (2015\u20132018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4338-1929","authenticated-orcid":false,"given":"Stefanie","family":"Desmet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbet Van","family":"Heirstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Malhotra-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Verhaegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy E","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Theeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2020.11.044_b0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.044_b0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-micro-090817-062338","article-title":"Pneumococcal vaccines: host interactions, population dynamics, and design principles","volume":"72","author":"Croucher","year":"2018","journal-title":"Annu Rev Microbiol"},{"issue":"9693","key":"10.1016\/j.vaccine.2020.11.044_b0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2020.11.044_b0020","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.044_b0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: Past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"22","key":"10.1016\/j.vaccine.2020.11.044_b0030","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","article-title":"Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: a systematic review of the literature","volume":"35","author":"Tsaban","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.11.044_b0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/INF.0000000000000751","article-title":"Decreased carriage and genetic shifts in the streptococcus pneumoniae population after changing the seven-valent to the thirteen-valent pneumococcal vaccine in Norway","volume":"34","author":"Steens","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2020.11.044_b0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.044_b0045","unstructured":"Mendes da Costa, E., et al., Infectieziekten bij kinderen, die voorkomen kunnen worden door vaccinatie, jaarrapport 2015. 2016, Wetenschappelijk Instituut Volksgezondheid, Brussel."},{"key":"10.1016\/j.vaccine.2020.11.044_b0050","unstructured":"Robert E, Swennen B. Enqu\u00eate de couverture vaccinale des enfants de 18 \u00e0 24 mois en F\u00e9d\u00e9ration Wallonie-Bruxelles (Bruxelles except\u00e9e). 2015, ULB: Bruxelles."},{"key":"10.1016\/j.vaccine.2020.11.044_b0055","unstructured":"Vandermeulen, C., Hoppenbrouwers, K., Roelants, M., Theeten, H., Braeckman, T., Maertens, K., Blaizot, S., Van Damme, P., Studie van de vaccinatiegraad in Vlaanderen, 2016. 2017, Vlaamse Overheid, Vlaams Agentschap Zorg en Gezondheid."},{"key":"10.1016\/j.vaccine.2020.11.044_b0060","unstructured":"Hoppenbrouwers, K., et al., Studie van de vaccinatiegraad bij jonge kinderen en adolescenten in Vlaanderen in 2008. 2009, Vlaamse Overheid, Vlaams Agentschap Zorg en Gezondheid."},{"key":"10.1016\/j.vaccine.2020.11.044_b0065","unstructured":"Robert E, Swennen B. Enqu\u00eate de couverture vaccinale des enfants de 18 \u00e0 24 mois en Communaut\u00e9 Fran\u00e7aise (Bruxelles except\u00e9) - Novembre 2009. 2010, ULB: Bruxelles."},{"issue":"8","key":"10.1016\/j.vaccine.2020.11.044_b0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1473-3099(18)30346-3","article-title":"Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?","volume":"18","author":"Desmet","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2020.11.044_b0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.vaccine.2018.12.068","article-title":"Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium","volume":"37","author":"Wouters","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.044_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vaccine.2017.11.052","article-title":"Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9years of pneumococcal conjugate vaccine programme","volume":"36","author":"Wouters","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.044_b0085","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.5.1900303","article-title":"How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018","volume":"25","author":"Wouters","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.11.044_b0090","unstructured":"Desmet S et al. Dynamic changes in Belgian pediatric invasive pneumococcal disease after sequential switch of conjugate vaccine: a national observational study. In press; 2020."},{"key":"10.1016\/j.vaccine.2020.11.044_b0095","unstructured":"CLSI. CLSI supplement M100. In: Performance Standards for Antimicrobial Susceptibility Testing, P. Wayne, Clinical and Laboratory Standards Institute, Editor. 2017."},{"key":"10.1016\/j.vaccine.2020.11.044_b0100","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017. 2017 [cited 2017; Available from: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_7.1_Breakpoint_Tables.pdf."},{"issue":"38","key":"10.1016\/j.vaccine.2020.11.044_b0110","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.11.044_b0115","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.11.044_b0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/1469-0691.12422","article-title":"High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines","volume":"20","author":"del Amo","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.044_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194823","article-title":"Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands","volume":"13","author":"Vissers","year":"2018","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2020.11.044_b0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jinf.2014.06.006","article-title":"Review: current and new generation pneumococcal vaccines","volume":"69","author":"Feldman","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.11.044_b0135","article-title":"Gebruik van de kinderopvang voor baby's en peuters, formele opvang in","author":"Kind & Gezin","year":"2017","journal-title":"Vlaams Gewest"},{"key":"10.1016\/j.vaccine.2020.11.044_b0140","article-title":"L'One en chiffres - L'accueil Petite Enfance","author":"ONE","year":"2017","journal-title":"Couverture de l'accueil."},{"key":"10.1016\/j.vaccine.2020.11.044_b0145","unstructured":"United States Patent Application. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof. 2015 August 2019]; Available from: http:\/\/patents.com\/us-20150202309.html."},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2020.11.044_b0150","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1099\/jmm.0.018390-0","article-title":"Serotype-specific invasive disease potential of Streptococcus pneumoniae in Czech children","volume":"59","author":"Zemlickova","year":"2010","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.044_b0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jinf.2018.06.004","article-title":"The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis","volume":"77","author":"Balsells","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.11.044_b0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12879-015-0978-9","article-title":"Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction","volume":"15","author":"Angoulvant","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"39","key":"10.1016\/j.vaccine.2020.11.044_b0165","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1016\/j.vaccine.2015.08.010","article-title":"A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation","volume":"33","author":"Cohen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.044_b0170","doi-asserted-by":"crossref","unstructured":"Camilli, R., et al., Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Vaccine, 2017. 35(35 Pt B): p. 4587-4593.","DOI":"10.1016\/j.vaccine.2017.07.010"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.044_b0175","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1073\/pnas.1812388116","article-title":"Unraveling the seasonal epidemiology of pneumococcus","volume":"116","author":"Domenech de Cell\u00e8s","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.11.044_b0180","series-title":"Pneumococcal Vaccines","author":"Lee","year":"2019"},{"issue":"10","key":"10.1016\/j.vaccine.2020.11.044_bib181","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/jcm.26.11.2465-2466.1988","article-title":"Numerical Index of the Discriminatory Ability of Typing Systems: an Application of Simpson\u2019s Index of Diversity","volume":"26","author":"Hunter","year":"1988","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:54:08Z","timestamp":1759402448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20314973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20314973"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-depth analysis of pneumococcal serotypes in Belgian children (2015\u20132018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}